Literature DB >> 25138336

Elevated serum ferritin.

Lisa B VanWagner1, Richard M Green2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25138336      PMCID： PMC4424930          DOI： 10.1001/jama.2014.302

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Liver biopsy.

Authors:  Don C Rockey; Stephen H Caldwell; Zachary D Goodman; Rendon C Nelson; Alastair D Smith
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

2.  Detection of iron overload.

Authors:  M J Pippard
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

Review 3.  Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Betsy A Garlitz; Emily L Harris; Tracy L Beil; Paula R Smith
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

4.  Factors that affect serum levels of ferritin in Australian adults and implications for follow-up.

Authors:  Elizabeth J McKinnon; Enrico Rossi; John P Beilby; Debbie Trinder; John K Olynyk
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-30       Impact factor: 11.382

5.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

6.  Causes and significance of markedly elevated serum ferritin levels in an academic medical center.

Authors:  Charles Moore; Michelle Ormseth; Howard Fuchs
Journal:  J Clin Rheumatol       Date:  2013-09       Impact factor: 3.517

7.  Iron-overload-related disease in HFE hereditary hemochromatosis.

Authors:  Katrina J Allen; Lyle C Gurrin; Clare C Constantine; Nicholas J Osborne; Martin B Delatycki; Amanda J Nicoll; Christine E McLaren; Melanie Bahlo; Amy E Nisselle; Chris D Vulpe; Gregory J Anderson; Melissa C Southey; Graham G Giles; Dallas R English; John L Hopper; John K Olynyk; Lawrie W Powell; Dorota M Gertig
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

8.  Screening for hemochromatosis in asymptomatic subjects with or without a family history.

Authors:  Lawrie W Powell; Jeannette L Dixon; Grant A Ramm; David M Purdie; Douglas J Lincoln; Gregory J Anderson; V Nathan Subramaniam; David G Hewett; Jeffrey W Searle; Linda M Fletcher; Darrell H Crawford; Helen Rodgers; Katrina J Allen; Juleen A Cavanaugh; Mark L Bassett
Journal:  Arch Intern Med       Date:  2006-02-13

9.  Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.

Authors:  Subhashini Chandrasekharan; Emily Pitlick; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

10.  Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Bruce R Bacon; Paul C Adams; Kris V Kowdley; Lawrie W Powell; Anthony S Tavill
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425
  10 in total
  2 in total

1.  Screening, identification of prostate cancer urinary biomarkers and verification of important spots.

Authors:  Huijun Zhao; Xuhong Zhao; Ting Lei; Man Zhang
Journal:  Invest New Drugs       Date:  2019-01-04       Impact factor: 3.850

2.  Examining the clinical use of hemochromatosis genetic testing.

Authors:  Matthew B Lanktree; Bruce B Lanktree; Guillaume Paré; John S Waye; Bekim Sadikovic; Mark A Crowther
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.